 It may be possible to exploit RNA interference in therapy . Although it is difficult to introduce long dsRNA strands into mammalian cells due to the interferon response , the use of short interfering RNA has been more successful . Among the first applications to reach clinical trials were in the treatment of macular degeneration and respiratory syncytial virus . RNAi has also been shown to be effective in reversing induced liver failure in mouse models . 
